Fate Therapeutics Inc - FATE - stock price prediction, stock price target, analyst ratings from 12 analysts

Fate Therapeutics Inc has a share price target of US$ 5, revenue growth forecast of -21.1%, and profit growth estimate of 2.7% for FY26, based on top 12 analyst calls.